What Does the MenB Vaccine Protect Against?
What Is Meningococcal Group B Disease?
Meningococcal disease is caused by a bacterium called
Neisseria meningitidis. It exists in several strains, identified by letters.
Group B is responsible for the majority of bacterial meningitis cases in the
UK. According to Meningitis Now
and Meningitis Research Foundation,
meningococcal group B accounts for roughly 60 per cent of all meningococcal
cases in the UK.
The disease can cause two distinct and serious conditions,
which may occur separately or at the same time:
Septicaemia, also known as blood poisoning, which can cause organ failure and tissue death.
Even with prompt treatment, meningococcal disease can be fatal
or leave survivors with lasting complications including hearing loss, brain
damage, limb amputation and scarring. Speed of diagnosis and treatment is
critical.
What Does the MenB Vaccine Protect Against?
The MenB vaccine used in the UK is called Bexsero,
manufactured by GSK. It is designed to protect against invasive meningococcal
group B disease, specifically the strains most prevalent in Europe and the UK.
According to NHS
data, the vaccine is estimated to protect against around 88 per cent of
meningococcal B strains circulating in the UK, though strain variation means no
vaccine offers complete coverage against every possible variant.
Bexsero does not protect against other meningococcal groups
such as A, C, W or Y. These are covered by separate vaccines, including the
MenACWY vaccine, which is offered to teenagers and young adults through the
NHS.
The MenB vaccine does not protect against viral meningitis,
which has a different cause and is generally less severe than bacterial forms.
|
Condition |
Covered by MenB Vaccine? |
Alternative Vaccine Available? |
|
Meningococcal group B disease |
Yes (approx. 88% of UK strains) |
— |
|
Meningococcal groups A, C, W, Y |
No |
Yes — MenACWY vaccine |
|
Viral meningitis |
No |
No specific vaccine |
|
Pneumococcal meningitis |
No |
Yes — pneumococcal vaccine (PCV) |
|
Haemophilus influenzae meningitis |
No |
Yes — Hib vaccine (in 6-in-1) |
Who Is Eligible for the MenB Vaccine on the NHS?
The NHS
immunisation schedule currently offers the MenB vaccine to:
•
Babies at 8 weeks, 16 weeks and 1 year old, as part of
the routine childhood immunisation programme.
•
Individuals with certain medical conditions that
increase the risk of meningococcal disease, such as asplenia, splenic
dysfunction or complement deficiency. These patients are offered the vaccine
through their GP or specialist.
The NHS does not routinely offer the MenB vaccine to older
children, teenagers or adults who fall outside these groups, even though
meningococcal B disease can affect people of all ages. There is a secondary
peak in incidence among teenagers and young adults, particularly those entering
university or college environments.
Can You Get the MenB Vaccine Privately?
Yes. Private MenB vaccination is available for those who are
not eligible under the NHS schedule or who wish to vaccinate older children and
adults outside the routine programme. This includes:
•
Children who missed their NHS schedule doses.
•
Older children and teenagers, particularly ahead of
starting secondary school or higher education.
•
Young adults, especially those moving into shared
accommodation such as university halls.
•
Travellers to regions with higher rates of
meningococcal disease.
•
Parents who want their child vaccinated earlier or on
an alternative schedule.
At Maple Leaf
Pharmacy, we can advise on private MenB vaccination and help you understand
whether it is appropriate for your circumstances. Speak to our pharmacy team or
book a consultation
to discuss your options.
What Are the Benefits of the MenB Vaccine?
Since the introduction of Bexsero into the NHS schedule in
2015, cases of meningococcal B disease in eligible age groups have fallen
significantly. Public Health England data showed a reduction of around 50 per
cent in confirmed MenB cases in infants in the years following introduction of
the programme.
The key benefits of MenB vaccine protection include:
•
Significantly reduced risk of invasive meningococcal B
disease in vaccinated individuals.
•
Reduced risk of severe complications including brain
damage, hearing loss and limb loss.
•
Contribution to herd immunity, reducing transmission
within communities.
•
Peace of mind for parents and individuals in
higher-risk groups or environments.
No vaccine is 100 per cent effective, and vaccinated
individuals should still be aware of meningitis symptoms. However, vaccination
remains the most effective available measure for meningitis B prevention.
Recognising Meningitis B Symptoms
Even for vaccinated individuals, knowing the warning signs of
meningococcal disease is important. Symptoms can develop rapidly and may not
all appear at once.
In Babies and Young Children
•
A high-pitched, unusual cry or moaning.
•
Bulging fontanelle (the soft spot on the top of the
head).
•
Floppy, unresponsive or difficult to wake.
•
Refusing feeds or vomiting.
•
Pale, blotchy or blue-tinged skin.
•
Fever, with cold hands and feet.
In Older Children and Adults
•
Sudden, severe headache.
•
Stiff neck.
•
Sensitivity to light.
•
High fever with cold extremities.
•
Nausea and vomiting.
•
A rash of red or purple spots or patches that does not
fade when pressed with a glass.
The non-blanching rash is a sign of septicaemia and requires
immediate emergency attention. Call 999 or go to A&E without delay. For a
full symptom guide, visit Meningitis
Research Foundation.
Get MenB Vaccination Advice at Maple Leaf Pharmacy
Whether you are asking about your child's NHS schedule, seeking private vaccination for an older child or teenager, or simply want to understand your options, our team at Maple Leaf Pharmacy is here to help. We serve patients across Richmond, Hampton, Teddington, Isleworth, Twickenham and Whitton. Book a consultation or visit us in person to discuss MenB vaccination.
Frequently Asked Questions (FAQ)
What does the MenB vaccine protect against?
It protects against invasive disease caused by meningococcal
group B bacteria, which is the most common cause of bacterial meningitis in the
UK, covering approximately 88 per cent of circulating UK strains.
Is the MenB vaccine free on the NHS?
Yes, for babies at 8 weeks, 16 weeks and 1 year old, and for
individuals with certain medical conditions. It is not routinely offered free
to older children, teenagers or adults outside these groups.
Can older children and adults get the MenB vaccine?
Yes, through private vaccination. The NHS does not routinely
offer MenB to those outside the infant schedule, but private vaccination is
available for older children, teenagers and adults who want protection.
Does the MenB vaccine protect against all types of meningitis?
No. It covers meningococcal group B only. Separate vaccines
are available for groups A, C, W and Y (MenACWY), pneumococcal meningitis and
Haemophilus influenzae type b.
What are the common side effects of the MenB vaccine?
Common side effects include redness, swelling and tenderness
at the injection site, fever, irritability and drowsiness, particularly in
infants. The NHS
recommends giving infant paracetamol after each of the first two doses to
reduce the risk of fever.
How do I know if my child has had their MenB vaccine?
Check your child's Red Book (Personal Child Health Record),
which records all vaccinations given as part of the NHS schedule. If you are
unsure, your GP practice can confirm the vaccination history.
Comments
Post a Comment